“Drug Pricing”

10 result(s)
Expensive Pill
Cost Management
Value-based management can only deliver on their promise of incremental cost-savings if the right guardrails are in place to ensure appropriate utilization and management. More
Briefing
Measuring Success
Cost Management
A few key metrics can help demonstrate how well a value-based management approach is working in helping align drug prices with the value and outcomes they deliver. More
Briefing
Aligning Drug Prices with Value
Cost Management
The current model of static, manufacturer-set drug prices is simply unsustainable. Value-based management approaches attempt to incentivize quality and efficacy. More
Briefing
Public Policy
A focus on prioritizing generic review and fostering competition could help in the battle against sky-rocketing prescription drug costs. More
Commentary
Cost Management
Members may now face higher out-of-pocket costs for their prescriptions, particularly during their deductible phase. Payors can help by applying rebates at point-of-sale. More
Feature
Public Policy
Lowering out-of-pocket consumer costs, ending manipulation and abuse of FDA regulations, and fostering greater competition can help lower high prescription drug costs. More
Commentary
Cost Management
Pharmaceutical manufacturers’ abuse a provision of the Orphan Drug Act leading to higher prices for drugs for payors and patients More
Feature
Speech bubbles icon
Cost Management
Spending on prescription drugs grew 9 percent in 2015 – faster than any other health care product or service – and accounted for 10 percent ($324.6 billion) of overall health care... More
Commentary
Pharmacist and line graph icon
Pharmacy Innovation
Being able to see into the future has to be every planner’s fantasy. As our ability to analyze and extract insights from data expands, this dream is becoming more and more of a... More
Feature
Container of pills
Cost Management
When thinking about price volatility – or inflation – most people think of gasoline. Not surprising, considering gas prices rose nearly 250 percent in the 13-year span from 1998... More
Feature